1.A Case of Angioleiomyoma on the Ear Helix.
Han Su KIM ; Heung Yeol KIM ; Eun Joo PARK ; Kwang Ho KIM ; Kwang Joong KIM
Korean Journal of Dermatology 2013;51(7):565-566
No abstract available.
Angiomyoma
;
Ear
2.A Case of Prurigo Pigmentosa on the Face.
Han Su KIM ; Byong Han SONG ; Eun Joo PARK ; Kwang Ho KIM ; Kwang Joong KIM
Korean Journal of Dermatology 2013;51(6):478-479
No abstract available.
Prurigo
3.A study on the menarche and the menstrual pattern of handicapped person.
Hyung Nam KIM ; Joong Il KIM ; Si Young JEONG ; Jae Sik SHIM ; Young Su JIN
Korean Journal of Obstetrics and Gynecology 1992;35(7):1025-1037
No abstract available.
Disabled Persons*
;
Female
;
Humans
;
Menarche*
4.A clinical study on Duchenne muscular dystrophy.
Moon Sun YANG ; Su Ahn CHAE ; Ki Joong KIM ; Yong Seung HWANG
Journal of the Korean Pediatric Society 1992;35(5):652-658
No abstract available.
Intellectual Disability
;
Muscle Weakness
;
Muscular Dystrophy, Duchenne*
6.The clinical study of subtrochanteric fractures of the femur.
Soo Kil KIM ; Keung Bae RHEE ; Sae Joong OH ; Su Chan LEE
The Journal of the Korean Orthopaedic Association 1992;27(4):1006-1013
No abstract available.
Femur*
;
Hip Fractures*
7.Extracutaneous mastocytoma of colon: a case report and literature review
Clinical Endoscopy 2022;55(6):810-814
Extracutaneous mastocytoma is a rare benign tumor composed of mature mast cells and is located in tissues other than the skin. We report the case of a 61-year-old male who was diagnosed with extracutaneous mastocytoma via colonoscopic polypectomy and biopsy. To our knowledge, this was the first case of a solitary extracutaneous mastocytoma of the colon. We reported this case and reviewed the literature.
8.The Expression of CLA(Cutaneous Lymphocyte-Associated Antigen) in the Cutaneous Lymphoma.
Jae Wang KIM ; Su Young KIM ; Kwang Joong KIM ; Jong Min KIM ; Chong Ju LEE ; Hyeong Sik SHIN
Korean Journal of Dermatology 1999;37(2):189-197
BACKGROUND: A pathogenesis of skin-homing lymphoid cells in primary cutaneous T-eell lymphoma(CTCL) has not been elucidated, CLA(cutaneous lymphocyte-associated antigen) defined by HECA-452 monoclonal anfibody has been proposed as the novel skin-homing receptors of infiltrative lymphocytes in atopic dermatitis and graft-versus-host disease. Accordingly, CLA may be a determinant explaining about the skin-homing properties of lymphoid tumor cells in CTCL. OBJECTIVE: This study was conducted to investigate the immunohistochemical expression of CLA in the lesional tissue specimens of cutaneous lymphomas. METHODS: Immunohistochemicslly, we examined the expression of CLA, E-selectin, ICAM-1 and LFA-1 antigens in the tissue specimens taken from the skin lesions and lymph nodes of the 22 patients with cutaneous lymphomas and the 20 control subjects with non-cutaneous lymphomas. Results : 1. The expression rate of CLA was 40.9% in the skin specimens of cutaneous lymphomas. We could not fad any expression of CLA in non-cutaneous lymphomas. 2. CTCL showed a more frequent expression of CLA(80%) than cutaneous B-cell lymphomas (CBCL)(8.3%). We found more frequently CLA+ high endothelial venules in non-cutaneous lymphomas(40%) than in cutaneous lymphomas(9.1%). 3. CLA and E-selectin were more frequently expressed in primary CTCL(100%, 83.3%) than in secondary CTCL(50%, 0%). 4. The positivity to ICAM-1 and LFA-1 antigens was higher in primary cutaneous lymphomas (72.7%, 81.8%) than in secondary forms(9.1%, 9.1%). Conclusion : CLA and E-selectin may represent the pivotal skin-homing receptor of infiltrative tumor cells and vascular counter-receptor in primary CTCL, respectively. Also, ICAM-1 and LFA-1 may have a role in the primary cutaneous infiltration of lymphoma cells as the additional cofactors.
Dermatitis, Atopic
;
E-Selectin
;
Flavin-Adenine Dinucleotide
;
Graft vs Host Disease
;
Humans
;
Intercellular Adhesion Molecule-1
;
Lymph Nodes
;
Lymphocyte Function-Associated Antigen-1
;
Lymphocytes
;
Lymphoma*
;
Lymphoma, B-Cell
;
Skin
;
Venules
9.Biopsy Induced Acquired Digital Fibrokeratoma.
Min Seok KIM ; Han Su KIM ; Eun Byul CHO ; Eun Joo PARK ; Kwang Ho KIM ; Kwang Joong KIM
Korean Journal of Dermatology 2014;52(11):835-836
No abstract available.
Biopsy*
10.Antiphospholipid Antibodies and Activated Protein C Resistance in Patients with Leg Ulcers.
Jae Wang KIM ; Su Young KIM ; Kwang Joong KIM ; Chong Ju LEE ; Byoung Geo CHO ; Kwang Hee LEE
Korean Journal of Dermatology 1999;37(2):133-140
BACKGROUND: Antiphospholipid antibodies(APA) including anticardiolipin antibodies(ACA) are significantly associated with ulcerations of the leg. Moreover, resistance to activated protein C(aPC) may be an important risk factor in leg ulcerations. Until now, there has been no clinical investigation about the positivity of APA or resistance to aPC in patients with leg ulcers in Korea. OBJECTIVE: We investigated the positivity to APA and the presence of resistance to aPC in patients with leg ulcers in Korea. METHODS: Venous or arterial ultrasonic Doppler, semiquantitative assay for serum APA and functional analysis for aPC resistance were conducted in 32 patients with leg ulcers. RESULTS: 1. Of the 32 patients with leg ulcers, 34,3% had a positive APA. APA were more frequently associated with venous ulcerations of the leg than in subjects with leg ulcers of arterial or mixed origin. 2. aPC resistance based upon the functional analysis, occurred in 43.7% to 46.8% of leg ulcer patients. 3. Livedo reticularis (38.1%) and superficial thrombophlebitis (19.0%) were the most common cutaneous manifestations accompanied by leg ulcers in 21 APA-positive and/or aPC resistant patients. Deep vein thrombosis of extremities was the most common complication (47.6%) among the systemic thrombotic sequelaes in APA-positive and/or aPC resistant patients. CONCLUSION: APA positivity and aPC resistance may be relatively common anticoagulant defects among patients with leg ulcerations in Korea. APA positivity and aPC resistance should be considered important risk factors for the development of not only leg ulcers but also systemic thrornbotic complications.
Activated Protein C Resistance*
;
Antibodies, Antiphospholipid*
;
Extremities
;
Humans
;
Korea
;
Leg Ulcer*
;
Leg*
;
Livedo Reticularis
;
Risk Factors
;
Thrombophlebitis
;
Ulcer
;
Ultrasonics
;
Varicose Ulcer
;
Venous Thrombosis